ABSTRACT. Mineralization was induced by glucocorticoid treatment in a human osteoblastic cell line derived from normal bone in vitro, designated SV-HFO, immortalized with simian virus 40 (CHIBA, H. et ah (1993). Jpn. J. Cancer Res. , 84: 290-297). Mineralization was revealed by electron microscopy, von Kossa staining and electron spectroscopic analysis, which indicated that the Ca/P ratio was approximately 1.70, corresponding to the value of hydroxyapatite. The effect was dose-(10"8-10~6 M) and time-dependent (days 7-28), was greatest at day 28, and was preceded by expression of alkaline phosphatase (ALP) and osteopontin (OPN). The ALP activity induced was highest at day 7, whereas OPNreached its highest level at day 28. When the induction of ALPactivity was inhibited by 10~4 Mlevamisole, mineralization of SV-HFOcells by glucocorticoid treatment was markedly reduced, suggesting that elevated ALP activity in the early phase is important in the mineralization of humanosteoblastic cells. Glucocorticoid treatment did not alter cell proliferation. These results indicated that glucocorticoids play crucial roles in the formation of mineralized matrix in human osteoblasts by inducing differentiation of SV-HFOcells without modulating their proliferative activity.
The process of bone formation is mostly studied in vitro by using established osteoblastic cells and osteosarcoma cell lines (ll, 42, 47) . It has been proposed that mineralized bone-like tissue is formed through sequential events which involve proliferation and differentiation of osteoblastic cells (32, 38, 39, 43, 50) . Normal humanosteoblastic cells, which were isolated from periosteum (28, 45) , trabecular bones (3, 10, 40) or bone marrow (2, 13, 19, 30) , have been used to study bone formation in humanbone in vitro. However, these cells frequently showalterations in phenotypic properties with increasing passage number, and the cells, including 1 To whomcorrespondence should be addressed at Department of Pathology, Sapporo Medical University School of Medicine, S.I, W.17, Chuo-ku, Sapporo 060, Japan. Abbreviations: alkaline phosphatase, ALP; osteopontin, OPN; osteocalcin, OC; la,25-dihydroxyvitamin D3, 1 ,25(OH)2D3; all-trans retinoic acid, RA; transforming growth factor-/3j, TGF-/3!; basic fibroblast growth factor, bFGF; interleukin-4, IL-4; a-minimal essential medium, a-MEM; fetal bovine serum, FBS; /3-glycerophosphate, /3-GP; N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid, HEPES; dexamethasone, Dex; hydrocortisone, HC; insulin, transferrin and selenious acid, ITS; calcium, Ca; phosphorus, P; electron spectroscopy for chemical analysis, ESCA; bromodeoxyuridine, BrdU; bovine serum albumin, BSA; saline sodium citrate, SSC; osteonectin, ON; a\ (I) procollagen, Col I; sodium dodecyl sulfate, SDS; digoxigenin, DIG.
HOBITcells, which are transfected with SV-40 large T antigen (27), eventually lose proliferative activity. Although several cell lines from humanosteosarcomas are also available, these cells do not fully express phenotypes of normal osteoblasts. In this sense, immortalized cell lines from normal human bone have long been desired to elucidate the molecular mechanisms by which humanbone tissues are formed and the therapeutic effects of various agents on ossification. Recently, we have established a novel osteoblastic cell line, designated SV-HFO, from normal human calvaria by immortalization with simian virus 40 (14) . The SVHFOcell line has a mesencymal nature, as revealed by phase-contrast, electron microscopic and immunohistochemical analyses. The cells produce low-level alkaline phosphatase (ALP) activity and osteocalcin (OC), and respond to la,25-dihydroxyvitamin D3 (1 ,25(OH)2D3), all-trans retinoic acid (RA) and transforming growth factor-^(TGF-/30 (14-17).
In the present study, we examined the process of mineralization in the SV-HFO cell line in vitro by treating the cells with glucocorticoids (8, 9, 20, 33), 1 ,25(OH)2D3 (4, 34), RA, basic fibroblast growth factor (bFGF) (35, 37), 46) and interleukin-4 (IL-4) (45) . We found that glucocorticoids induced mineralization of SV-HFOcells in a dose-and time-dependent Cells were cultured in a-MEMcontaining 10% FBS, 10 mM/3-glycerophosphate and one of the above factors for 4 weeks. Mineralization was determined by von Kossa staining. Vit D3: la,25-dihydroxyvitamin D3, Dex: dexamethasone, HC: hydrocortisone, RA: all-trans retinoic acid TGF-^: transforming growth factor-^, bFGF: basic fibroblast growth factor, manner and that elevation of ALPactivity in the early stage is crucial for the development of mineralization.
MATERIALS AND METHODS
Cell culture. The SV-HFOcell line was established as described previously (14) . The cells at passage 14 were seeded at a cell density of 1 x 104 cells/cm2 on 100-mm or 35-mm culture dishes (Corning Glass Works, Corning, NY) in a-minimal essential medium (a-MEM; Gibco Laboratories, Grant Island, NY) supplemented with 10% fetal bovine serum (FBS; JRH Bioscience, Lenexa, KS), 10 mM/3-glycerophosphate (/3-GP;
Sigma Chemical
Co., St. Louis, MO), lOOU/ml penicillin and 100^g/ml streptomycin (Immuno Biological Laboratories, Fujioka, Japan) and 20 mMN-2-hydroxyethylpipera- Ultrastructural analysis. For transmission electron microscopy, the cells were fixed in a mixture of 1%glutaraldehyde
and 4% paraformaldehyde in cacodylate buffer (pH 7.4) at 4°C for 30 min. They were then post fixed with 1% OsO4, dehydrated, and embedded in Epon 812. Ultrathin sections were stained with uranyl acetate and lead citrate, and examined with a JEOL1200-Ex transmission electron microscope.
Electron spectroscopy for chemical analysis (ESCA). The cells were fixed in a mixture of 1%glutaraldehyde and 4% paraformaldehyde in cacodylate buffer, pH 7.4, at 4°C for 30 min, dehydrated, and dried at room temperature. These cell layers were scraped and examined for the compositions of Ca and P with an electron spectrometer (Shimazu ESCA-850, Kyoto Japan).
Analysis of growth properties. At the 1st, 3rd, 5th, 7th, 14th, 21st and 28th days after plating, cultured cells were dispersed in 0.05% trypsin and 0.02% EDTA, and the cell number was counted in a hemocytometer using 0. 15%trypan blue in PBS. For monitoring of DNAsynthesis, the cells were incubated with bromodeoxyuridine (BrdU) for 12 hr, fixed in absolute ethanol, and BrdUincorporation was determined using a cell proliferation kit (Amersham International Pic, Amersham, UK).
Measurement ofALPactivity. The cells were rinsed twice with PBS, scraped in 0.5 ml of a solution containing 0.1% Triton X-100, 10mM Tris-HCl (pH7.5), 1 mMMgCl2 and 0.02% NaN3, and sonicated for 5 sec. The cells were centrifuged at 10,000g at 4°C for 5 min, and the supernatant was kept frozen at -20°C until use. ALPactivity was spectrophotometrically measured using p-nitrophenyl phosphate as a substrate. The content of cellular protein was measured by using a Pierce BCAprotein assay kit (Pierce Chemical Co., Rock ford, IL) using bovine serum albumin (BSA) as a standard. ALPactivity was expressed as nanomoles/min/mgprotein.
Measurement of osteocalcin synthesis. To avoid contamination of serum osteocalcin (OC) from FBS, the medium was changed to serum-free medium24 hrs before measurement. The amount of OCsecreted into the culture mediumwas determined by radioimmunoassay using a commercially available kit (CIS Biointernational, Gif-Sur-Yvette, France). Results were expressed as nanograms/dish.
Northern blot analysis. Total RNAs were isolated from cell cultures using the single-step thiocyanate-phenol-chloroform extraction method (18) as modified by Xie and Rothblum (49) . For electrophoresis, 10 ptg of total RNAwas loaded on \% agarose gel containing 0.5 /^g/ml ethidium bro- To detect mRNAof ON, OPN and OC, digoxigenin (DIG)-labeled RNAprobes were prepared from their cDNAsusing an RNAlabeling kit (Boehringer Mannheim, Mannheim, Germany), and hybridization, washing and chemiluminescent detection were carried out following the DIGluminescent proto- Days after plating as in the presence of serum (data not shown). Dex induced mineralization in a dose-dependent manner, with the maximal effect at 10~6 M (Fig. 3) . Only 1-day treatment of cells with 10~6 MDex was sufficient to induce mineralization, although the degree was low compared to that of cells continuously treated with Dex. (Fig. 4) . Mineralization induced by Dex always required about 2 weeks after the beginning of Dex addition even after the cells reached con fluent cell density, regardless of the concentration of Dex. Biochemical detection of minerals. Ca and P became biochemically detectable in cultures treated with 10~6 MDex at day 14, and their amounts increased significantly during culture. Ca and P acummulation was not detected in control culture (Fig. 5) . The effect of Dex on mineral deposition was dose-dependent, being maximal at 10~6 M (Fig. 6 ). These data were consistent with the results obtained from von Kossa staining. Ultrastructural analysis. Transmission electron microscopy was performed on the SV-HFOcells cultured in the presence or absence ofDex for 14 or 28 days. Elec- tron-dense deposits were observed amongextracellular collagen fibrils of osteoblastic cells in Dex-treated cultures (Fig. 7) , but not in the control. These structures were conspicuous at day 28 compared to day 14. Electron spectroscopy for chemical analysis. The deposited minerals were composedof Ca and P, as revealed by ESCA.The Ca/P ratio was approximately 1.70, which corresponded with the value of hydroxyapatite (Fig. 8) .
Growthproperties. The dose of 10~6 M Dex had no effect on the cell number of SV-HFOcells (Fig. 9) and BrdU incorporation (data not shown). ALP activity and levamisole treatment. As shown in Fig. 10 , 10~6 M Dex significantly increased ALP activityin the SV-HFOcells at days 7, 14, 21 and 28. The maximal activity was an over 10-fold increase at day 7, which then decreased during culture ( reduced whenthe cells were cultured in the presence of levamisole, which significantly reduced Dex-induced ALPactivity to approximately the control level at the 2nd, 4th and 7th days after treatment. (Figs. ll and 12) . Analysis of gene expression of bone differentiated proteins. Wefurther examined the changes in the expression ofALP, Col I, ON OPNand OC mRNAsin SV-HFOcells cultured with or without 10-6M Dex (Fig. 13) . Dex significantly induced the ALP mRNAexpression, which was maximal at day 7 and gradually decreased, consistent with the changes in the activity of ALPduring Dex-treatment. The expression of Col I and ONmRNAs,maximal at day 7, was not influenced by Dex. OPNmRNAexpression was significantly induced in Dex-treated culture. In particular, 3-and 4-week treatment with Dex markedly induced OPNexpression, corresponding to the degree of mineralization. OCmRNA was not detected in the cells cultured with or without Dex. As described previously (15, 16), SV-HFO cells produced only a small amount of OC, a specific osteoblast differentiation marker. However, Dex did not influence OCsynthesis during culture (data not shown).
DISCUSSION
In the present study, we showed that Dex induced mineralization of human osteoblastic cells in vitro. We also demonstrated that enhanced expression of ALP and OPN was induced in SV-HFOcells by Dex. In particular, a close relationship between the ALPexpression at the early stage and the OPNexpression at the late stage and mineralization was revealed.
Mineralization in the matrix of SV-HFO cells required the addition of glucocorticoids.
Treatment of SV-HFOcells with Dex for only one day was sufficient for the induction of mineralization that occurred at day 14 in culture, although the degree of mineralization was lower than in the cells continuously treated with Dex. For mineralization of the cells induced by Dex, 2 weeks were always needed after the beginning of treatment. It has been suggested that glucocorticoids have a permissive effect on the differentiation of osteoprogenitor cells obtained from nonhuman sources (7-9, 20, 26, 29, 31, 33, 50) . Recently, Cheng et al. (13) have documented that glucocorticoids induce the differentiation of human bone marrow stromal cells into osteoblasts. These findings suggested that the SV-HFOcells were osteoprogenitor cells, which can be committed to mineralization by treatment with glucocorticoids. calvaria (1, 7, 38), whereas it inhibits proliferation of the cells isolated from human trabecular bone (48) and human bone marrow (13) in primary cultures. Thus, there might be a species difference in responsiveness of osteoblastic cells to glucocorticoids. In this study, however, the proliferation of SV-HFOcells was not influenced by Dex. This discrepancy might be explained by the hypothesis that SV-40 large T antigen functionally inactivates Rb and p53 proteins and interferes with the effects of growth factors or hormones on cell proliferation (5, 6). Furthermore, since mineralization of SVHFOcells reaching con fluent cell density also requires 2 weeks, Dexseems to regulate differentiation of osteoblast lineage in a manner independent of proliferative regulation.
During bone formation, osteoblasts secrete a number of bone-related proteins, many of which are integrated into the type I collagen-based scaffolding of bone matrix. Using prolonged primary cultures of fetal rat calvarial cells, Stein and coworkers described sequential events involved in this proliferation and differentiation (38, 43) . These chronological patterns are also observed in chick (21, 41), mouse (39), and bovine (25) osteoblastic cells, and in rat bone marrow cells (32, 50) . In the present study, to elucidate sequential changes in the expression of bone-related proteins during bone-like tissue formation in humans, the expression of various osteoblastic markers was examined. Of these markers, ALP activity and the expression of OPNwere significantly induced by Dex, with maximal effects at day 7 and day 28, respectively. Dex-induced mineralization was significantly reduced when the cells were cultured with 10~4 Mlevamisole, in which conditions Dex-induced ALP activity was reduced to approximately the control level. Under such conditions, mineralization by SV-HFOcells was significantly inhibited. These results suggest that a certain level of ALP activity in early stages is required for mineralization. Elevation of ALPactivity was followed by the expression of bone-related proteins such as OPN, which are further required for the formation of bone-like tissues. Several investigators have indicated, using different culture systems (25, 32, 38, 50) , that the expression of OPNincreases temporally, reaches its peak when mineralization begins, and then gradually decreases with mineralization. In our system, Dex induced expression of OPNwith culture time at least until day 28, corresponding to the degree of mineralization. Recently, Hirota et al. showedthat the expression of OPN,not ON, is deeply related to the degree of calcification in human atherosclerotic lesions (23). Thus, the bone matrix protein OPNmay play an important role in the formation of mineral deposits in human bone tissues. SV-HFOis the first immortalized cell line from normal humanbone that forms bone-like tissues as far as we know. Since mineralization of SV-HFOcells was inducedby Dex, the cells can serve as an appropriate tool for studies of the mechanismsand regulatory factors of bone formation in humanbones.
